Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$6.92 -0.16 (-2.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Phathom Pharmaceuticals (PHAT) Other Accumulated Expenses (2018 - 2026)

Updated

Phathom Pharmaceuticals' Other Accumulated Expenses was $6.93 million in Q2 2026, up 42.3% from $4.87 million a year earlier and up 23.5% from the prior quarter.

Analysis

Phathom Pharmaceuticals (PHAT) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Phathom Pharmaceuticals came in at $7.5 million, up 146.4% from FY2024.

  • Other Accumulated Expenses has now increased for five consecutive years, with a five-year compound annual growth rate of 88.9% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $3.04 million in FY2024 (+165.6%), $1.15 million in FY2023 (+34.2%), $854,000 in FY2022 (+79.0%) and $477,000 in FY2021 (+52.9%).
  • Quarterly Other Accumulated Expenses has moved between $214,000 (Q3 2021) and $7.5 million (Q4 2025) over five years.
  • Compared with a year earlier, Other Accumulated Expenses has increased for five straight quarters, with growth averaging 116.8% over the last eight quarters.
  • The best year-over-year quarter for Other Accumulated Expenses over five years was Q1 2024 (growth of 267.9%); the worst was Q3 2021 (a decline of 29.1%).
  • Per Business Quant data, PHAT's Other Accumulated Expenses in the three quarters before Q2 2026 was $5.61 million (Q1 2026), $7.5 million (Q4 2025) and $4.79 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Phathom Pharmaceuticals 554.08 Mn -85.87 Mn 59.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.93 Mn
Mar 31, 2026 5.61 Mn
Dec 31, 2025 7.50 Mn
Sep 30, 2025 4.79 Mn
Jun 30, 2025 4.87 Mn
Mar 31, 2025 2.81 Mn
Dec 31, 2024 3.04 Mn
Sep 30, 2024 1.79 Mn
Jun 30, 2024 1.43 Mn
Mar 31, 2024 3.35 Mn
Dec 31, 2023 1.15 Mn
Sep 30, 2023 957,000.00
Jun 30, 2023 927,000.00
Mar 31, 2023 911,000.00
Dec 31, 2022 854,000.00
Sep 30, 2022 686,000.00
Jun 30, 2022 565,000.00
Mar 31, 2022 481,000.00
Dec 31, 2021 477,000.00
Sep 30, 2021 214,000.00
API Access

Phathom Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PHAT&period=max&api_key=YOUR_API_KEY